Bioventus Inc.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain trea…
Medical - Devices
US, Durham [HQ]
BVS/Financial Reporting
Income Statements
12 Sheets · Starting from 2013In Million USD. Margins, Growth Rates In %
| Metric | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 1999 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 232.00 | 242.00 | 253.00 | 274.00 | 292.00 | 319.00 | 340.00 | 321.00 | 430.00 | 64.00 | 512.00 | 512.00 | |
|
EPS
|
-0.40 | -0.23 | -0.61 | -0.32 | -0.03 | -0.22 | -0.01 | 0.08 | 0.16 | - - | -3.48 | -2.49 | |
| Diluted in mil. | -0.40 | -0.23 | -0.61 | -0.32 | -0.03 | -0.22 | -0.01 | 0.08 | 0.16 | - - | -3.48 | -2.49 | |
|
Profit
|
161.00 | 168.00 | 179.00 | 183.00 | 199.00 | 235.00 | 249.00 | 233.00 | 302.00 | 45.00 | 331.00 | 328.00 | |
| Gross Margin | 69.29 | 69.28 | 70.69 | 66.71 | 68.47 | 73.63 | 73.27 | 72.71 | 70.25 | 70.72 | 64.65 | 64.06 | |
| Pre Tax | -20.00 | -11.00 | -31.00 | -5.00 | 8.00 | 6.00 | 9.00 | 15.00 | 7.00 | -39.00 | -263.00 | -121.00 | |
| Profit Margin | -8.71 | -4.67 | -12.60 | -2.06 | 2.96 | 1.91 | 2.85 | 4.96 | 1.77 | -60.35 | -51.53 | -23.64 | |
| ETR | -10.51 | -13.63 | -6.69 | -19.30 | -9.07 | 27.25 | 16.27 | - - | - - | - - | - - | - - | |
| Net | -22.00 | -12.00 | -34.00 | -17.00 | -1.00 | -12.00 | 6.00 | 16.00 | 9.00 | -39.00 | -213.00 | -156.00 | |
| Profit Margin | -9.63 | -5.31 | -13.45 | -6.54 | -0.56 | -3.82 | 2.01 | 5.11 | 2.22 | -60.55 | -41.67 | -30.49 | |
| EBITDA | 15.00 | 34.00 | 15.00 | 48.00 | 59.00 | 54.00 | 61.00 | 50.00 | 51.00 | -16.00 | -109.00 | -23.00 | |
| EBITDA Margin | 7.05 | 13.02 | 15.23 | 17.72 | 20.31 | 17.66 | 18.27 | 17.09 | 12.21 | -25.45 | 6.08 | -4.50 | |
| Operating Income | -8.00 | - - | -16.00 | 14.00 | 27.00 | 25.00 | 31.00 | 21.00 | 17.00 | -35.00 | -35.00 | -81.00 | |
| Operating Margin | -3.47 | 0.01 | -6.54 | 5.42 | 9.25 | 7.99 | 9.17 | 6.61 | 4.11 | -55.07 | -6.97 | -15.95 | |
| Interest Income | - - | - - | - - | - - | - - | - - | 21.00 | 9.00 | 1.00 | - - | 25.00 | - - | |
| Loss | -240.00 | -240.00 | -248.00 | -259.00 | -265.00 | -291.00 | -308.00 | -299.00 | -409.00 | -100.00 | -560.00 | -594.00 | |
| Cost of Revenue | -71.00 | -74.00 | -74.00 | -91.00 | -92.00 | -84.00 | -90.00 | -87.00 | -128.00 | -18.00 | -181.00 | -184.00 | |
|
Operating Expenses
|
-169.00 | -165.00 | -173.00 | -168.00 | -172.00 | -207.00 | -217.00 | -211.00 | -281.00 | -81.00 | -379.00 | -409.00 | |
| R&D | -10.00 | -9.00 | -14.00 | -7.00 | -8.00 | -8.00 | -11.00 | -11.00 | -19.00 | -4.00 | -25.00 | -13.00 | |
| G&A | - - | - - | - - | - - | - - | - - | -196.00 | -190.00 | -250.00 | -33.00 | -327.00 | -300.00 | |
| SG&A | -150.00 | -147.00 | -148.00 | -160.00 | -164.00 | -191.00 | -198.00 | -193.00 | -254.00 | -76.00 | -332.00 | -303.00 | |
| S&M | - - | - - | - - | - - | - - | - - | -2.00 | -2.00 | -3.00 | -42.00 | -5.00 | -3.00 | |
| Depreciation and Amortization | -24.00 | -28.00 | -33.00 | - - | - - | -29.00 | -30.00 | - - | - - | - - | - - | - - | |
| Interest Expenses | -11.00 | -11.00 | -14.00 | -15.00 | -18.00 | -19.00 | -21.00 | -9.00 | -1.00 | -3.00 | -25.00 | -40.00 | |
| Other Expenses | -12.00 | -11.00 | -15.00 | -20.00 | -18.00 | -19.00 | -21.00 | -5.00 | -2.00 | -3.00 | -21.00 | -39.00 | |
|
WA Shares Outstanding
|
55.00 | 55.00 | 55.00 | 56.00 | 56.00 | 55.00 | 56.00 | 56.00 | 59.00 | - - | 61.00 | 62.00 | |
| Diluted | 55.00 | 55.00 | 55.00 | 56.00 | 56.00 | 55.00 | 56.00 | 56.00 | 59.00 | - - | 61.00 | 62.00 |